Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Davis

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
The Journal of Clinical Investigation|March 5, 2019
BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironmentSujan Piya, Hong Mu, Seemana Bhattacharya, et al.
Journal of the National Cancer Institute|June 28, 2018
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in GliomaKhatri Latha, Jun Yan, Yuhui Yang, et al.
International Journal of Cancer|April 29, 2014
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphomaKui Shin Voo, Myriam Foglietta, Elena Percivalle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2018
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell LymphomasLan V Pham, Shengjian Huang, Hui Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2018
Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191Haiwen Ni, Fazal Shirazi, Veerabhadran Baladandayuthapani, et al.
Nature|January 2, 2009
Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survivalNicolas Bidère, Vu N Ngo, Jeansun Lee, et al.
Leukemia Research|August 13, 2022
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insightsNaveen Pemmaraju, Nathaniel R Wilson, Jayastu Senapati, et al.
Scientific Reports|June 10, 2015
Reactive Liftoff of Crystalline Cellulose ParticlesAndrew R Teixeira, Christoph Krumm, Katherine P Vinter, et al.
Blood Advances|March 29, 2019
Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysisJuliet N Barker, Kirsten Boughan, Parastoo B Dahi, et al.
Blood|August 31, 2012
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myelomaDeborah J Kuhn, Zuzana Berkova, Richard J Jones, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
The Journal of Clinical Investigation|March 5, 2019
BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironmentSujan Piya, Hong Mu, Seemana Bhattacharya, et al.
Journal of the National Cancer Institute|June 28, 2018
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in GliomaKhatri Latha, Jun Yan, Yuhui Yang, et al.
International Journal of Cancer|April 29, 2014
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphomaKui Shin Voo, Myriam Foglietta, Elena Percivalle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2018
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell LymphomasLan V Pham, Shengjian Huang, Hui Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2018
Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191Haiwen Ni, Fazal Shirazi, Veerabhadran Baladandayuthapani, et al.
Nature|January 2, 2009
Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survivalNicolas Bidère, Vu N Ngo, Jeansun Lee, et al.
Leukemia Research|August 13, 2022
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insightsNaveen Pemmaraju, Nathaniel R Wilson, Jayastu Senapati, et al.
Scientific Reports|June 10, 2015
Reactive Liftoff of Crystalline Cellulose ParticlesAndrew R Teixeira, Christoph Krumm, Katherine P Vinter, et al.
Blood Advances|March 29, 2019
Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysisJuliet N Barker, Kirsten Boughan, Parastoo B Dahi, et al.
Blood|August 31, 2012
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myelomaDeborah J Kuhn, Zuzana Berkova, Richard J Jones, et al.
Pageof 17